Elevatus Welath Management’s HCA Healthcare HCA Stock Holding History

Elevatus Welath Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Sell	556 -8	-1%	-$3.38K	0.05%	231
2026 Q1	$267K	Buy	564 +6	+1%	+$3.02K	0.14%	113
2025 Q4	$260K	Sell	558 -10	-2%	-$4.64K	0.07%	128
2025 Q3	$242K	Buy	568 +3	+0.5%	+$1.16K	0.07%	115
2025 Q2	$217K	Sell	565 -36	-6%	-$13K	0.07%	110
2025 Q1	$208K	Buy	+601	New	+$193K	0.12%	98
2024 Q4	–	Sell	-666	Closed	-$271K	–	112
2024 Q3	$271K	Hold	666	–	–	0.09%	75
2024 Q2	$214K	Buy	666 +1	+0.2%	+$325	0.08%	95
2024 Q1	$222K	Buy	+665	New	+$203K	0.09%	86
2023 Q3	–	Sell	-666	Closed	-$202K	–	76
2023 Q2	$202K	Buy	+666	New	+$185K	0.14%	50

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Elevatus Welath Management's HCA Position: Q2 2026 in Review

Elevatus Welath Management reduced its HCA Healthcare (HCA) stake by 1.4% in Q2 2026, selling an estimated $3.38K and leaving 556 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #231.

Elevatus Welath Management first reported a position in HCA in Q2 2023 and has held it in 10 quarters since. The position peaked at $271K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Elevatus Welath Management held 556 shares of HCA Healthcare worth $217K as of Q2 2026.
Elevatus Welath Management sold 8 HCA Healthcare shares in Q2 2026, an estimated $3.38K.
HCA Healthcare made up 0.05% of Elevatus Welath Management's portfolio in Q2 2026, its #231 holding.
Elevatus Welath Management first reported a position in HCA Healthcare in Q2 2023 and has held it in 10 quarters since.
Elevatus Welath Management's HCA Healthcare position peaked at $271K in Q3 2024.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Elevatus Welath Management's 13F filing for Q2 2026, filed 13 Aug 2026.